StockNews.AI
THTX
StockNews.AI
129 days

Soleus Capital Issues Letter to The Board of Theratechnologies

1. Soleus Capital supports pursuing an acquisition for THTX to benefit shareholders. 2. Futu has announced an acquisition offer for Theratechnologies.

2m saved
Insight
Article

FAQ

Why Bullish?

Acquisition interest generally drives stock prices up, similar to prior M&A activity. Historical cases show shares rallying on acquisition speculations.

How important is it?

Active interest from a large stakeholder increases acquisition probability, directly affecting THTX's valuation.

Why Short Term?

Immediate investor reactions expected as discussions progress; similar situations in biotech show quick movements.

Related Companies

FUTUAMGNBIIB
GREENWICH, Conn.--(BUSINESS WIRE)--Soleus Capital Management, L.P. (“Soleus Capital”), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ: THTX) (the “Company”), today sent a letter to the Board of Directors of the Company. In its letter, Soleus Capital described its belief that an acquisition of the Company is in the best interest of the Company's shareholders and urged the Board to pursue an acquisition offer announced earlier today by Futu.

Related News